Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:01 PM
Ignite Modification Date:
2025-12-24 @ 3:01 PM
NCT ID:
NCT00433459
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically confirmed classical Hodgkin's lymphoma
* No lymphocyte-predominant Hodgkin's lymphoma
* Fine-needle biopsy not sufficient
* No prior treatment for Hodgkin's lymphoma except for recommended pre-phase therapy for a large mediastinal tumor
PATIENT CHARACTERISTICS:
* No known hypersensitivity or contraindication to study drugs
* No other current malignancy
* No severe concurrent disease (e.g., immune deficiency syndrome)
* Not pregnant or nursing
* Fertile patients must use effective contraception during and for up to 1 year after completion of study treatment
* No known HIV positivity
PRIOR CONCURRENT THERAPY:
* See Disease Characteristics
* No prior chemotherapy or radiotherapy
* At least 30 days since prior and no other concurrent investigational drugs or participation in another investigational trial
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
17 Years
Study:
NCT00433459
Study Brief:
Protocol Section:
NCT00433459